Key facts
- This page summarizes Matthew Link's Form 4 filing for Sight Sciences, Inc. (SGHT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 07 Jul 2025, 21:24.
Matthew Link - 02 Jul 2025 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- SGHT
- Reported as of
- 02 Jul 2025
- Net transaction value
- -$20,035
- SEC form
- 4
- Accepted by SEC
- 07 Jul 2025, 21:24:01 UTC
- Prior SEC filing
- 12 Jun 2025
- Next SEC filing
- 03 Sep 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeremy Hayden, Attorney-in-Fact for Matthew Link
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Matthew Link filed Form 4 for Sight Sciences, Inc. (SGHT) on 07 Jul 2025.
Change
- Previous filing in this sequence was filed on 12 Jun 2025.
- Current net transaction value: -$20,035.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001565950
Primary reporting owner
Link Matthew
- Relationship
- Chief Commercial Officer
- Address
- C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK
- Signature
- /s/ Jeremy Hayden, Attorney-in-Fact for Matthew Link
- Signature date
- 07 Jul 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SGHT
transaction
Common Stock
Sale
- Transaction value
- $20,035
- Shares
- -4,889
- Change %
- -0.58%
- Price
- $4.10
- Shares after
- 832,293
- Date
- 02 Jul 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.